MNBTD
FOLD

Moody National Bank Trust Division’s Amicus Therapeutics FOLD Stock Holding History

Moody National Bank Trust Division’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-528
Closed -$5K – 1252
2018
Q4 		$5K Buy
+528
New +$5.8K ﹤0.01% 775

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Moody National Bank Trust Division's FOLD Position: Q1 2019 in Review

Moody National Bank Trust Division sold out of Amicus Therapeutics (FOLD) in Q1 2019, closing a stake of 528 shares — an estimated $5K sold.

Moody National Bank Trust Division first reported a position in FOLD in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 205 funds tracked by Wall St. Rank hold FOLD as of Q1 2019.

  • Moody National Bank Trust Division reported no remaining Amicus Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 528 Amicus Therapeutics shares in Q1 2019, an estimated $5K.
  • Moody National Bank Trust Division first reported a position in Amicus Therapeutics in Q4 2018 and held it in 1 quarter.
  • Moody National Bank Trust Division's Amicus Therapeutics position peaked at $5K in Q4 2018.
  • 205 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2019.

Based on Moody National Bank Trust Division's 13F filing for Q1 2019, filed 11 Apr 2019.